287 related articles for article (PubMed ID: 9202867)
1. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
Thompson CH; Irish AB; Kemp GJ; Taylor DJ; Radda GK
Clin Nephrol; 1997 Jun; 47(6):372-8. PubMed ID: 9202867
[TBL] [Abstract][Full Text] [Related]
2. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P
Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic uraemia on skeletal muscle metabolism in man.
Thompson CH; Kemp GJ; Taylor DJ; Ledingham JG; Radda GK; Rajagopalan B
Nephrol Dial Transplant; 1993; 8(3):218-22. PubMed ID: 8385287
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle metabolism before and after gemfibrozil treatment in dialysed patients with chronic renal failure.
Thompson CH; Irish A; Kemp GJ; Taylor DJ; Radda GK
Clin Nephrol; 1996 Jun; 45(6):386-9. PubMed ID: 8793231
[TBL] [Abstract][Full Text] [Related]
5. Uraemic muscle metabolism at rest and during exercise.
Thompson CH; Kemp GJ; Barnes PR; Rajagopalan B; Styles P; Taylor DJ; Radda GK
Nephrol Dial Transplant; 1994; 9(11):1600-5. PubMed ID: 7870350
[TBL] [Abstract][Full Text] [Related]
6. Reduced mitochondrial adenosine triphosphate synthesis in skeletal muscle in patients with Child-Pugh class B and C cirrhosis.
Jacobsen EB; Hamberg O; Quistorff B; Ott P
Hepatology; 2001 Jul; 34(1):7-12. PubMed ID: 11431727
[TBL] [Abstract][Full Text] [Related]
7. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
8. The time course of haemodynamic, autonomic and skeletal muscle metabolic abnormalities following first extensive myocardial infarction in man.
Adamopoulos S; Kemp GJ; Thompson CH; Arnolda L; Brunotte F; Stratton JR; Radda GK; Rajagopalan B; Kremastinos DT; Coats AJ
J Mol Cell Cardiol; 1999 Oct; 31(10):1913-26. PubMed ID: 10525428
[TBL] [Abstract][Full Text] [Related]
9. The effect of erythropoietin on lactate, pyruvate and excess lactate under physical exercise in dialysis patients.
Meierhenrich R; Jedicke H; Voigt A; Lange H
Clin Nephrol; 1996 Feb; 45(2):90-7. PubMed ID: 8846536
[TBL] [Abstract][Full Text] [Related]
10. Carnitine: a false dawn in the treatment of muscle weakness in end-stage renal failure patients?
Davenport A
Nephron Clin Pract; 2004; 97(2):c33-4. PubMed ID: 15218327
[No Abstract] [Full Text] [Related]
11. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
[TBL] [Abstract][Full Text] [Related]
12. Impaired muscle oxygen metabolism in uremic children: improved after renal transplantation.
Matsumoto N; Ichimura S; Hamaoka T; Osada T; Hattori M; Miyakawa S
Am J Kidney Dis; 2006 Sep; 48(3):473-80. PubMed ID: 16931221
[TBL] [Abstract][Full Text] [Related]
13. Carnitine and peripheral arterial disease.
Hiatt WR
Ann N Y Acad Sci; 2004 Nov; 1033():92-8. PubMed ID: 15591006
[TBL] [Abstract][Full Text] [Related]
14. Phosphocreatine synthesis by isolated rat skeletal muscle mitochondria is not dependent upon external ADP: a 31P NMR study.
Kernec F; Le Tallec N; Nadal L; Bégué JM; Le Rumeur E
Biochem Biophys Res Commun; 1996 Aug; 225(3):819-25. PubMed ID: 8780696
[TBL] [Abstract][Full Text] [Related]
15. Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy.
Sinnwell TM; Sivakumar K; Soueidan S; Jay C; Frank JA; McLaughlin AC; Dalakas MC
J Clin Invest; 1995 Jul; 96(1):126-31. PubMed ID: 7615782
[TBL] [Abstract][Full Text] [Related]
16. Dialysis-related carnitine disorder.
Hedayati SS
Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive assessment of oxidative capacity in young Indian men and women: a 31P magnetic resonance spectroscopy study.
Rana P; Varshney A; Devi MM; Kumar P; Khushu S
Indian J Biochem Biophys; 2008 Aug; 45(4):263-8. PubMed ID: 18788477
[TBL] [Abstract][Full Text] [Related]
18. Abnormal mitochondrial function and muscle wasting, but normal contractile efficiency, in haemodialysed patients studied non-invasively in vivo.
Kemp GJ; Crowe AV; Anijeet HK; Gong QY; Bimson WE; Frostick SP; Bone JM; Bell GM; Roberts JN
Nephrol Dial Transplant; 2004 Jun; 19(6):1520-7. PubMed ID: 15004250
[TBL] [Abstract][Full Text] [Related]
19. Abnormal ATP turnover in rat leg muscle during exercise and recovery following myocardial infarction.
Thompson CH; Kemp GJ; Rajagopalan B; Radda GK
Cardiovasc Res; 1995 Mar; 29(3):344-9. PubMed ID: 7781009
[TBL] [Abstract][Full Text] [Related]
20. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
